Apple Watch Sales Up 50 Percent over Last Year


Apple Watch pic
Apple Watch

Dr. Sanjiv Narayan serves as a professor of medicine at Stanford University, where he is the co-founder and co-director of the Stanford Arrhythmia Center. In his personal life, Dr. Sanjiv M. Narayan maintains an interest in wearable technologies like the Apple Watch.

During an early August investor call, Apple CEO Tim Cook revealed that the company’s Apple Watch has seen sales rise more than 50 percent from last year’s figures. Creative Strategies analyst Ben Bajarin estimates the company’s flagship wearable sold somewhere between 2 to 3 million units.

Though the reason for the uptick in sales is uncertain, TechCrunch suggests two potential reasons. First is compatibility with the company’s wireless AirPod earbuds. The other possible reason is the general downturn in sales for other wearables from companies like Fitbit and Jawbone, the latter of which is poised to go out of business.

Apple is currently planning the release of watchOS 4, which will further integrate Siri and also promises “an entirely new music experience.” WatchOS 4 is scheduled for release sometime in the fall of 2017.

An Innovative Approach to Treating Sleep Apnea


Sleep Apnea pic
Sleep Apnea

A professor of medicine at Stanford University, Dr. Sanjiv Narayan is responsible for treating patients and conducting research related to the development of innovative solutions for patients suffering from heart arrhythmias. Over the course of his career, Sanjiv M. Narayan has also developed an interest in breathing disorders, specifically sleep apnea.

Sleep apnea, a disorder that affects over 18 million Americans, causes patients to experience multiple disruptions in their breathing throughout the night. The disorder can drastically increase a patient’s chance of heart attack or stroke.

The standard treatment for those suffering from sleep apnea involves the use of a continuous positive airway pressure (CPAP) machine. While this treatment helps improve a patient’s sleep, it doesn’t help prevent heart attack or stroke.

With those limitations in mind, a new device has been developed for those with severe sleep apnea. When the CPAP machine is not effective, doctors may recommend therapy that revolves around a pacemaker-like device. Inspire therapy involves surgically placing an implant within a patient’s chest along with two thin wires that run under the skin to monitor breathing. When breathing is obstructed, the device delivers a mild electrical current to the hypoglossal nerve, which controls the movement of the tongue; these key airway muscles then move back into a healthy position. The device is controlled by a handheld remote so that it is only utilized during night time hours.

Inspire therapy is recommended for patients with moderate to severe obstructive sleep apnea who do not experience a consistent benefit from a CPAP machine. Patients must also be over the age of 22 and not significantly overweight.